Abstract:Peptide drugs are increasingly used to treat a variety of diseases ranging from cancer, and infections to cardiovascular diseases. However, peptides can suffer from low stability in the bloodstream. Entrapment of peptides into nano-sized carriers of various types has widely been explored, but all of them have spherical shapes. Nanocellulose can in contrast serve as a non-spherical nanoparticle with a high aspect ratio. After the isolation of nanocellulose by TEMPO-mediated oxidation, the material needs to be modified with polymers to generate nanoparticles with high water-solubility that can also favourably interact with peptide drugs. We have here chosen insulin as the model drug, which can strongly interact with cationic polymers. As it is known that cationic polymer may retain charged drugs too tightly, we have selected poly(2-(dimethylamino)ethyl acrylate) PDMAEA as a degradable polymer that undergoes self-hydrolysis to poly(acrylic acid) in water. This polymer was compared to poly(N-(3-(dimethylamino)propyl) acrylamide) PDMAPAA, which is a stable cationic polymer. The cationic polymer was co-grafted with poly(2-hydroxyethyl acrylate) PHEA as a water-soluble neutral polymer using the three-component Passerini reaction. A combination of fluorescence and UV-Vis techniques were used to quantify the amount of polymer that was conjugated to the surface. The polymer-coated nanocellulose was labelled with the fluorescent cyanine dye Cy5 while insulin was labelled with Cy3 creating a FRET system that allows monitoring of the interaction between insulin and polymer in cell growth media. We observed that despite the self-hydrolysis of PDMAEA into a negatively charged polymer, the negatively charged insulin was not released in buffer solution according to the FRET studies. Only the addition of serum-supplemented cell growth media led to insulin release. The limited release was explained with the fact that insulin, as well as other peptides, have a mixture of negative and positive charges, with the pH value and the isoelectric point determining the balance between both. Negative-charged polymers can therefore still interact favourably with negatively charged peptides by interacting with cationic amino acids.

A Poly(l-Lysine)-based Hydrophilic Star Block Co-Polymer As a Protein Nanocarrier with Facile Encapsulation and Ph-Responsive Release

A non-spherical nanoparticles system for the delivery of peptides using polymer grafted nanocellulose

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

Phenylboronic Acid-Containing Block Copolymers: Synthesis, Self-Assembly, and Application for Intracellular Delivery of Proteins

Preparation and Characterization of Insulin Nanoparticles Employing Chitosan and Poly(methylmethacrylate/methylmethacrylic Acid) Copolymer.

Water Soluble Star-Block Copolypeptides: Towards Biodegradable Nanocarriers for Versatile and Simultaneous Encapsulation

Polyelectrolyte-protein synergism: pH-responsive polyelectrolyte/insulin complexes as versatile carriers for targeted protein and drug delivery

A Thin Polymer Layer Enables Peptide‐Polycation Complexes with Ultrahigh Efficient Encapsulation

Preparation of Gel-Core-Solid Lipid Nanoparticle: A Novel Way to Improve the Encapsulation of Protein and Peptide

Oral Delivery of Protein Drugs via Lysine Polymer‐Based Nanoparticle Platforms

Amphiphilic QP(DMAEMA-co-LMA)-b-POEGMA Random-Block Terpolymers As Nanocarriers for Insulin

Synthesis and characterization of polycation block copolymer Poly(l-lysine)-b-poly[N-(N′,N′-diisopropyl-aminoethyl)aspartamide] as potential pH responsive gene delivery system

Preparation and characterization of drug-loaded PLA/PEG/PLA triblock copolymer nanocapsules

Synthesis and physicochemical characterization of a novel amphiphilic polylactic acid-hyperbranched polyglycerol conjugate for protein delivery

Synthesis and characterization of star-shaped block copolymer of poly-(ε-caprolactone) and poly(ethyl ethylene phosphate) as drug carrier

Development of Cationic Polymer-Based Nanoplatform for Insulin Delivery and Diabetes Treatment

Well-defined degradable brush-coil block copolymers for intelligent release of insulin at physiological pH

A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles.

Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels

Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin.

Galactose-based polymer-containing phenylboronic acid as carriers for insulin delivery